These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 953673)

  • 21. Mucosal irritation following use of gentian violet.
    Slotkowski EL; Redondo D
    Am J Dis Child; 1966 Jul; 112(1):40-2. PubMed ID: 4951362
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated.
    Jurevic RJ; Traboulsi RS; Mukherjee PK; Salata RA; Ghannoum MA;
    Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):629-33. PubMed ID: 21210170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of subinhibitory concentrations of gentian violet on the germ tube formation by Candida albicans and its adherence to oral epithelial cells.
    Mafojane T; Shangase SL; Patel M
    Arch Oral Biol; 2017 Oct; 82():1-5. PubMed ID: 28575640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gentian violet.
    Harris MJ
    Med J Aust; 1991 Jun; 154(11):782. PubMed ID: 2046587
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of the use of gentian violet in dermatology practice.
    Pona A; Quan EY; Cline A; Feldman SR
    Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral candidosis. A review of the literature and a retrospective study of 91 patients].
    Jensen PS; Holst E
    Ugeskr Laeger; 1969 Jul; 131(29):1229-39. PubMed ID: 5811512
    [No Abstract]   [Full Text] [Related]  

  • 27. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
    Nyst MJ; Perriens JH; Kimputu L; Lumbila M; Nelson AM; Piot P
    Ann Soc Belg Med Trop; 1992 Mar; 72(1):45-52. PubMed ID: 1567268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida infection of the tongue.
    Yassin A; Mostafa MA; Moawad MK
    J Laryngol Otol; 1966 Feb; 80(2):138-50. PubMed ID: 5905548
    [No Abstract]   [Full Text] [Related]  

  • 29. [Candidiasis].
    Alexander M
    Med Klin; 1972 Sep; 67(39):1233-5. PubMed ID: 4565308
    [No Abstract]   [Full Text] [Related]  

  • 30. Gentian violet is safe.
    Arbiser JL
    J Am Acad Dermatol; 2009 Aug; 61(2):359. PubMed ID: 19615548
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
    Su CW; Gaskie S; Jamieson B; Triezenberg D
    J Fam Pract; 2008 Jul; 57(7):484-5. PubMed ID: 18625176
    [No Abstract]   [Full Text] [Related]  

  • 32. [Necroses following the use of Pyoktanin].
    Sommer G; Happle R
    Hautarzt; 1977 Feb; 28(2):92-3. PubMed ID: 845034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necrotic skin reactions caused by 1 per cent gentian violet and brilliant green.
    Björnberg A; Mobacken H
    Acta Derm Venereol; 1972; 52(1):55-60. PubMed ID: 4111108
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted therapy of oral hairy leukoplakia with gentian violet.
    Bhandarkar SS; MacKelfresh J; Fried L; Arbiser JL
    J Am Acad Dermatol; 2008 Apr; 58(4):711-2. PubMed ID: 18342722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy.
    Kim SJ; Koh DH; Park JS; Ahn HS; Choi JB; Kim YS
    Yonsei Med J; 2003 Feb; 44(1):163-5. PubMed ID: 12619193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [THE ROLE OF CANDIDA IN CHILDHOOD PATHOLOGY].
    TUEMAY SB; CETIN ET; YUECEL A
    Tip Fak Mecm; 1963; 26():364-72. PubMed ID: 14126606
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of the umbilicus with crystal violet solution.
    Bale MS
    Can Med Assoc J; 1981 Feb; 124(4):372-3. PubMed ID: 7214266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Response to letter to the editor 23(1): 53, 1990: Risk of cancer development in recipients of gentian violet-treated blood. Validity of the interview].
    Luquetti AO
    Rev Soc Bras Med Trop; 1990; 23(4):237-8. PubMed ID: 2133593
    [No Abstract]   [Full Text] [Related]  

  • 39. Candidal vulvovaginitis treatment with a new non-staining, non-messy gentian violet.
    KARNAKY KJ
    Ariz Med; 1958 Aug; 15(8):578-81. PubMed ID: 13560272
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of and therapy for vaginal candidiasis.
    PICKHARDT WL; BREEN JL
    Am J Obstet Gynecol; 1957 Jul; 74(1):42-6. PubMed ID: 13435281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.